Latest Share Chat

IN BRIEF: Drug maker Sareum plans 50-into-1 share consolidation

Fri, 04th Feb 2022 14:37

Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - Calls extraordinary general meeting for February 28 to approve a 50-into-1 share consolidation. Sareum says its current large number of shares, at 3.40 billion, and low share price create a negative perception among investors. Reducing the number of shares by a factor of 50 will increase the share price and make the stock "more attractive to a broader range of investors", it says.

Current stock price: 3.92 pence

12-month change: doubled from 1.90p

By Tom Waite; thomaslwaite@alliancenews.com

Related Shares

More News

19 Apr 2024 12:16

IN BRIEF: Sareum falls as issues shares to RiverFort Global

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company - Issues 3.0 million new shares in the company to RiverFort Global Opportunities...

4 Apr 2024 17:24

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

2 Apr 2024 17:35

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

28 Mar 2024 13:44

EARNINGS AND TRADING: Northamber loss widens; Ethernity contract boost

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

15 Mar 2024 13:11

Sareum allowed European patent for primary kinase inhibitor asset

(Sharecast News) - Biotechnology company Sareum announced on Friday that the European Patent Office had issued a notice of allowance for a patent conc...